Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans
PLOS Pathogens · 31.10.2023 · 19 (10) · e1011730
DOI: 10.1371/journal.ppat.1011730 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 31.10.2023. Verfasst von Mohamad A Nasrallah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, …. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Caenorhabditis elegans Proteins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Sphingolipids are required for diverse biological functions and are degraded by specific catabolic enzymes. However, the mechanisms that regulate sphingolipid catabolism are not known. Here we characterize a transcriptional axis that regulates sphingolipid breakdown to control resistance against bacterial infection. From an RNAi screen for transcriptional regulators of pathogen resistance in the nematode C . elegans , we identified the nuclear hormone receptor nhr-66 , a ligand-gated transcription factor homologous to human hepatocyte nuclear factor 4. Tandem chromatin immunoprecipitation-sequencing and RNA sequencing experiments revealed that NHR-66 is a transcriptional repressor, which directly targets sphingolipid catabolism genes. Transcriptional de-repression of two sphingolipid catabolic enzymes in nhr-66 loss-of-function mutants drives the breakdown of sphingolipids, which enhances host susceptibility to infection with the bacterial pathogen Pseudomonas aeruginosa . These data define transcriptional control of sphingolipid catabolism in the regulation of cellular sphingolipids, a process that is necessary for pathogen resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Program in Innate Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
- Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
ORCID-Profile: Read Pukkila-Worley
Förderung
- NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Nasrallah, M. A., Peterson, N. D., Szumel, E. S., Liu, P., Page, A. L., Tse, S. Y., Wani, K. A., Tocheny, C. E., & Pukkila-Worley, R. (2023). Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans. PLOS Pathogens, 19(10), e1011730. https://doi.org/10.1371/journal.ppat.1011730
Vancouver
Nasrallah MA, Peterson ND, Szumel ES, Liu P, Page AL, Tse SY, et al. Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans. PLOS Pathogens. 2023;19(10):e1011730. doi:10.1371/journal.ppat.1011730
BibTeX
@article{Nasrallah2023,
author = {Nasrallah, Mohamad A and Peterson, Nicholas D and Szumel, Elizabeth S and Liu, Pengpeng and Page, Amanda L and Tse, Samantha Y and Wani, Khursheed A and Tocheny, Claire E and Pukkila-Worley, Read},
title = {Transcriptional suppression of sphingolipid catabolism controls pathogen resistance in C. elegans},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {10},
pages = {e1011730},
doi = {10.1371/journal.ppat.1011730}
}
EUVIMED